2026. PREDICTING REFRACTORY CANCER PAIN USING MACHINE LEARNING INTEGRATION OF CLINICAL, IMAGING, GENOMIC, AND OPIOID-RESPONSE PROFILES. Spectrum of Research and Reviews. 4, 1 (Jun. 2026), 1–18.